Analysis

Intuit (INTU) set to report Q1 FY26 results. Here’s what to expect

Intuit Inc. (NASDAQ: INTU) is preparing to report results for the first three months of fiscal 2026, amid expectations for a double-digit

Estee Lauder’s (EL) Beauty Reimagined strategy is paying off, a few points to note

Shares of The Estée Lauder Companies Inc. (NYSE: EL) stayed green on Friday. The stock has gained 20% year-to-date. After going through

Disney’s (DIS) streaming business continues its momentum in Q4 2025

Shares of The Walt Disney Company (NYSE: DIS) fell 9% on Thursday after the company delivered mixed results for the fourth quarter

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Omnichannel push, margin dynamics in focus as Walmart gears up for Q3 earnings

Walmart Inc. (NYSE: WMT) entered the second half of FY26 navigating a challenging retail landscape marked by tariff-related cost pressure and cautious consumer behavior. At the same time, the company

November 13, 2025

AMAT Earnings: Applied Materials Q4 adjusted profit drops on lower revenues

Semiconductor equipment maker Applied Materials, Inc. (NASDAQ: AMAT) on Thursday reported a decrease in adjusted earnings for the fourth quarter of fiscal 2025. Adjusted earnings declined to $2.17 per share

November 13, 2025

Disney’s (DIS) streaming business continues its momentum in Q4 2025

Shares of The Walt Disney Company (NYSE: DIS) fell 9% on Thursday after the company delivered mixed results for the fourth quarter of 2025. While earnings beat expectations, revenues fell

November 13, 2025

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top